Novel predictors of intrapulmonary vascular dilatations in cirrhosis: Extending the role of pulse oximetry and echocardiography

Acta Gastro-Enterologica Belgica

Volumn 76, Issue 2, 2013, Pages 241-245

  Voiosu, A ^a   Voiosu, T ^a   Stanescu C M ^a   Chirila L ^a   Baicus C ^a   Voiosu, R ^a  

^a Carol Davila School of Medicine   (Romania)

Author keywords

Cirrhosis; Cirrhotic cardiomyopathy; Contrast enhanced echocardiography; Hepatopulmonary syndrome; Pulse oximetry

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HEART RIGHT VENTRICLE; HEART VENTRICLE SIZE; HUMAN; INTRAPULMONARY VASCULAR DILATATION; LIVER CIRRHOSIS; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; PHYSICAL EXAMINATION; PREDICTIVE VALUE; PROSPECTIVE STUDY; PULMONARY VASCULAR DISEASE; PULSE OXIMETRY; STANDING; SUPINE POSITION; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84886864224     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pavarino P.R., Corbucci H.A., de Marchi C.H., da Mata P.F., de Godoy M.F. Contrast echocardiography in the diagnosis of intrapulmonary vascular dilations in candidates for liver transplantation. Arq. Bras. Cardiol., 2004 Jun, 82 (6): 515-522.
2. Lenci I., Alvior A., Manzia T.M., Toti L., Neuberger J., Steeds R.J. Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantation. Am. Soc. Echocardiogr., 2009 Jan, 22 (1): 89-94.
3. Mimidis K.P., Karatza C., Spiropoulos K.V., Toulgaridis T., Charokopos N.A., Thomopoulos K.C. et al. Prevalence of intrapulmonary vascular dilatations in normoxaemic patients with early liver cirrhosis. Scand. J. Gastroenterol., 1998 Sep, 33 (9): 988-992.
4. El Makarem M.A., Elakad A., Ali A., Abd-Elkader M., Sayed A.F., Taha A. et al. Hepatopulmonary syndrome: prevalence and predictors in Egyptian cirrhotic patients. Trop. Gastroenterol., 2011 Jan-Mar, 32 (1): 25-30.
5. Lange P.A., Stoller J.K. The hepatopulmonary syndrome. Ann. Intern. Med., 1995, 122: 521-529.
6. Pouriki S., Alexopoulou A., Chrysochoou C., Raftopoulos L., Papatheodoridis G., Stefanadis C. et al. Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome. Liver Int., 2011 Oct, 31 (9): 1388-1394.
7. Møller S., Henriksen J.H. Cirrhotic cardiomyopathy. J. Hepatol., 2010 Jul, 53 (1): 179-190.
8. Wong F. Cirrhotic cardiomyopathy. Hepatol. Int., 2009 Mar, 3 (1): 294-304.
9. Cazzaniga M., Salerno F., Pagnozzi G., Dionigi E., Visentin S., Cirello I. et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut, 2007, 56: 869-875.
10. Cremona G., Higenbottam T.W., Mayoral V., Alexander G., Demoncheaux E., Borland C. et al. Elevated nitric oxide in patients with hepatopulmonary syndrome. Eur. Respir. J., 1995, 8: 1883-1885.
11. Tang L., Luo B., Patel R.P., Ling Y., Zhang J., Fallon M.B. Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol., 2007 Jun, 292 (6): L1467-1472.
12. Nunes H., Lebrec D., Mazmanian M., Capron F., Heller J., Tazi K.A. et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am. J. Respir. Crit. Care Med., 2001 Sep 1, 164 (5): 879-885.
13. Liu H., Ma Z., Lee S.S. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology, 2000 May, 118 (5): 937-944.
14. Mandell M.S. Clinical controversies surrounding the diagnosis and treatment of hepatopulmonary syndrome. Minerva Anestesiol., 2007 Jun, 73 (6): 347-355.
15. Mohammad Alizadeh A.H., Fatemi S.R., Mirzaee V., Khoshbaten M., Talebipour B., Sharifian A. et al. Clinical features of hepatopulmonary syndrome in cirrhotic patients. World J. Gastroenterol., 2006 Mar 28, 12 (12): 1954-1956.
16. Rodríguez-Roisin R., Krowka M.J. Hepatopulmonary syndrome-a liver-induced lung vascular disorder. N. Engl. J. Med., 2008 May 29, 358 (22): 2378-2387.
17. Rodríguez-Roisin R., Krowka M.J., Hervé P., Fallon M.B. Pulmonary-Hepatic vascular Disorders. Eur. Respir. J., 2004, 24: 861-880.
18. Kochar R., Tanikella R., Fallon M.B. Serial pulse oximetry in hepatopulmonary syndrome. Dig. Dis. Sci., 2011 Jun, 56 (6): 1862-1868.
19. Abrams G.A., Sanders M.K., Fallon M.B. Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl., 2002 Apr, 8 (4): 391-396.
20. Arguedas M.R., Singh H., Faulk D.K., Fallon M.B. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin. Gastro enterol. Hepatol., 2007 Jun, 5 (6): 749-754.
21. Deibert P., Allgaier HP., Loesch S., Müller C., Olschewski M., Hamm H. et al. Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry. BMC Gastroenterol., 2006, 6: 15.
22. Zamirian M., Aslani A., Shahrzad S. Left atrial volume: a novel predictor of hepatopulmonary syndrome. Am. J. Gastroenterol., 2007, 102: 1392-1396.
23. Zamirian M., Aslani A., Sharifkazemi M.B. Prediction of intra pulmonary right to left shunt with left atrial size in patients with liver cirrhosis. Eur. J. Echocardiogr., 2008 Jan, 9 (1): 1-4.
24. Miyata-Fukuoka Y., Izumo M., Shimada Y., Kuwahara E., Gurudevan S.V., Tolstrup K. et al. Left Atrial Size and Function Are Related to Pulmonary Hypertension in Coronary Artery Disease. Echo cardiography, 2012 May, 29 (5): 535-540.
25. Karabulut A., Iltumur K., Yalcin K., Toprak N. Hepatopulmonary syndrome and right ventricular diastolic functions: an echocardiographic examination. Echocardiography, 2006 Apr, 23 (4): 271-278.
26. Celermajer D.S., Marwick T. Echocardiographic and right heart catheterization techniques in patients with pulmonary arterial hypertension. Int. J. Cardiol., 2008 Apr 25, 125 (3): 294-303.
27. Er F., Ederer S., Nia A.M., Caglayan E., Dahlem K.M., Semmo N. et al. Accuracy of Doppler-echocardiographic mean pulmonary artery pressure for diagnosis of pulmonary hypertension. PLoS One., 2010 Dec 17, 5 (12): e15670.
28. Galiè N., Hoeper M.M., Humbert M., Torbicki A., VachieryJ.L., Barbera J.A. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur. Heart J., 2009 Oct, 30 (20): 2493-2537.
29. Colle I.O., Moreau R., Godinho E., Belghiti J., Ettori F., Cohen-Solal A. et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology, 2003 Feb, 37 (2): 401-409.
30. Pozzi M., Redaelli E., Ratti L., Poli G., Guidi C., Milanese M. et al. Time-course of diastolic dysfunction in different stages of chronic HCV related liver diseases. Minerva Gastroenterol. Dietol., 2005, 51: 179-186.
31. Kasner M., Westermann D., Steendijk P., Gaub R., Wilkenshoff U., Weitmann K. et al. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation, 2007 Aug 7, 116 (6): 637-647.
32. Møller S., Henriksen J.H. Cardiovascular complications of cirrhosis. Gut, 2008 Feb, 57 (2): 268-278.